AR002739A1 - Un procedimiento para la preparacion de hidrocloruro de lercanidipino y el clorhidrato de metiloanhidro 1,1,n-trimetil-n-(3,3-difenilpropil)-2-aminoetilo-1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-piridino-3,5-dicarboxilato obtenido mediante dicho procedimiento. - Google Patents

Un procedimiento para la preparacion de hidrocloruro de lercanidipino y el clorhidrato de metiloanhidro 1,1,n-trimetil-n-(3,3-difenilpropil)-2-aminoetilo-1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-piridino-3,5-dicarboxilato obtenido mediante dicho procedimiento.

Info

Publication number
AR002739A1
AR002739A1 ARP960102528A AR10252896A AR002739A1 AR 002739 A1 AR002739 A1 AR 002739A1 AR P960102528 A ARP960102528 A AR P960102528A AR 10252896 A AR10252896 A AR 10252896A AR 002739 A1 AR002739 A1 AR 002739A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
methylanhydrochlorhydrate
difenilpropil
dicarboxilato
Prior art date
Application number
ARP960102528A
Other languages
English (en)
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of AR002739A1 publication Critical patent/AR002739A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un procedimiento para la preparación de 1,1,N-trimetil-N-(3,3- difenilpropil)-2-aminoetil 1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-piridin-3,5-dicarboxilato de metilo (lercanidipino) comprende la reacción de un halogenuro de ácido 2,6-dimetil-5-metoxicarbonil-4-(3-nitrofenil)-1,4-dihidropiridin-3-carboxílico con 2,N-dimetil-N-(3,3-difenilpropil)-1-amino-2- propanol en un disolvente aprótico. El producto puede ser aislado mediantetécnicas de cristalización industrialmente aplicables y se obtiene con un gran rendimiento con su clorhidrato anhidro, una forma que posee una estabilidadelevada y una baja higroscopicidad.
ARP960102528A 1995-05-12 1996-05-10 Un procedimiento para la preparacion de hidrocloruro de lercanidipino y el clorhidrato de metiloanhidro 1,1,n-trimetil-n-(3,3-difenilpropil)-2-aminoetilo-1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-piridino-3,5-dicarboxilato obtenido mediante dicho procedimiento. AR002739A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI950957A IT1274480B (it) 1995-05-12 1995-05-12 Procedimento migliorato per la preparazione della lercanidipina cloridrato

Publications (1)

Publication Number Publication Date
AR002739A1 true AR002739A1 (es) 1998-04-29

Family

ID=11371581

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102528A AR002739A1 (es) 1995-05-12 1996-05-10 Un procedimiento para la preparacion de hidrocloruro de lercanidipino y el clorhidrato de metiloanhidro 1,1,n-trimetil-n-(3,3-difenilpropil)-2-aminoetilo-1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-piridino-3,5-dicarboxilato obtenido mediante dicho procedimiento.

Country Status (37)

Country Link
EP (1) EP0824517B1 (es)
JP (1) JP4038622B2 (es)
KR (1) KR100395441B1 (es)
CN (1) CN1101810C (es)
AR (1) AR002739A1 (es)
AT (1) ATE221050T1 (es)
AU (1) AU694046B2 (es)
BG (1) BG62400B1 (es)
BR (1) BR9608374A (es)
CA (1) CA2217849C (es)
CZ (1) CZ288634B6 (es)
DE (1) DE69622552T2 (es)
DK (1) DK0824517T3 (es)
DZ (1) DZ2032A1 (es)
EA (1) EA000346B1 (es)
EE (1) EE03351B1 (es)
EG (1) EG21755A (es)
ES (1) ES2179942T3 (es)
HU (1) HU226709B1 (es)
IL (1) IL118143A (es)
IN (1) IN188486B (es)
IT (1) IT1274480B (es)
MA (1) MA23858A1 (es)
MX (1) MX9708662A (es)
MY (1) MY113802A (es)
NO (1) NO309423B1 (es)
NZ (1) NZ309059A (es)
PL (1) PL185260B1 (es)
PT (1) PT824517E (es)
RO (1) RO119616B1 (es)
SA (1) SA96170216B1 (es)
SK (1) SK283321B6 (es)
TN (1) TNSN96069A1 (es)
TW (1) TW404940B (es)
UA (1) UA46769C2 (es)
WO (1) WO1996035668A1 (es)
ZA (1) ZA963716B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
JP2006504800A (ja) * 2002-10-16 2006-02-09 レコーダチ アイルランド リミテッド リシノプリル／レルカニジピンの組み合わせ治療
AR052918A1 (es) * 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
KR100713136B1 (ko) * 2005-05-04 2007-05-02 주식회사 대희화학 무수 레르카니디핀 염화수소 결정다형의 개선된 신규결정화 방법
ATE445602T1 (de) 2005-06-15 2009-10-15 Hetero Drugs Ltd Neues verfahren zur herstellung von lercanidipin
WO2007031865A2 (en) 2005-09-16 2007-03-22 Glenmark Pharmaceuticals Limited Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
KR100811497B1 (ko) * 2005-10-19 2008-03-07 신풍제약주식회사 무수 염산 1,4-디하이드로피리딘 유도체의 제조 방법
DE602006003877D1 (de) * 2006-05-24 2009-01-08 Cf Pharma Ltd Verfahren zur Herstellung von Lercanipidin
KR100808281B1 (ko) * 2006-06-30 2008-03-03 주식회사 하원정밀화학 레르카니디핀 및 그 산부가염의 제조방법
CN102020602B (zh) * 2009-09-18 2013-12-25 深圳信立泰药业股份有限公司 盐酸乐卡地平晶型及其制备方法和含有该晶型的药物组合物
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
SI2654729T1 (sl) 2010-12-24 2016-08-31 Krka, D.D., Novo Mesto Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102516160B (zh) * 2011-12-16 2014-04-02 华润赛科药业有限责任公司 一种高纯盐酸乐卡地平的合成工艺
CN102584682A (zh) * 2011-12-31 2012-07-18 苏州二叶制药有限公司 盐酸乐卡地平的制备方法
CN109956943B (zh) * 2019-04-18 2021-07-20 合肥合源药业有限公司 一种二氢吡啶类药物中脱羧缩合杂质及其制备、控制方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
DE69622552D1 (de) 2002-08-29
SK283321B6 (sk) 2003-06-03
AU5898596A (en) 1996-11-29
SK151497A3 (en) 1998-05-06
ATE221050T1 (de) 2002-08-15
CZ356797A3 (cs) 1998-04-15
BG102034A (en) 1998-04-30
KR19990008378A (ko) 1999-01-25
MA23858A1 (fr) 1996-12-31
MY113802A (en) 2002-05-31
ES2179942T3 (es) 2003-02-01
JP4038622B2 (ja) 2008-01-30
BR9608374A (pt) 1999-08-24
IL118143A0 (en) 1996-09-12
CZ288634B6 (cs) 2001-08-15
NO975176D0 (no) 1997-11-11
EA000346B1 (ru) 1999-04-29
RO119616B1 (ro) 2005-01-28
PL185260B1 (pl) 2003-04-30
EG21755A (en) 2002-02-27
CA2217849A1 (en) 1996-11-14
DK0824517T3 (da) 2002-11-18
TW404940B (en) 2000-09-11
ZA963716B (en) 1996-11-20
IN188486B (es) 2002-10-05
CA2217849C (en) 2007-09-11
NO975176L (no) 1997-11-11
HUP9801913A3 (en) 1999-01-28
KR100395441B1 (ko) 2004-02-05
CN1101810C (zh) 2003-02-19
HUP9801913A2 (hu) 1998-12-28
WO1996035668A1 (en) 1996-11-14
NO309423B1 (no) 2001-01-29
ITMI950957A0 (it) 1995-05-12
JPH11504932A (ja) 1999-05-11
ITMI950957A1 (it) 1996-11-12
EP0824517A1 (en) 1998-02-25
PT824517E (pt) 2002-12-31
HU226709B1 (en) 2009-07-28
IL118143A (en) 2001-06-14
TNSN96069A1 (fr) 2005-03-15
UA46769C2 (uk) 2002-06-17
SA96170216B1 (ar) 2005-12-21
EP0824517B1 (en) 2002-07-24
NZ309059A (en) 1998-10-28
PL323236A1 (en) 1998-03-16
AU694046B2 (en) 1998-07-09
BG62400B1 (bg) 1999-10-29
EA199700374A1 (ru) 1998-10-29
IT1274480B (it) 1997-07-17
EE03351B1 (et) 2001-02-15
DE69622552T2 (de) 2003-01-23
CN1184468A (zh) 1998-06-10
MX9708662A (es) 1998-08-30
DZ2032A1 (fr) 2002-07-21

Similar Documents

Publication Publication Date Title
AR002739A1 (es) Un procedimiento para la preparacion de hidrocloruro de lercanidipino y el clorhidrato de metiloanhidro 1,1,n-trimetil-n-(3,3-difenilpropil)-2-aminoetilo-1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-piridino-3,5-dicarboxilato obtenido mediante dicho procedimiento.
DK0534520T3 (da) Fremgangsmåde til fremstilling af 4-substituerede 1,4-dihydropyridiner
UA6344A1 (uk) Спосіб одержання бензолсульфонатної солі 3-етіл-5метілового ефіру 2-(2-аміноетоксіметіл)-4-(2-хлорфеніл)-6-метіл-1,4-дігідропірідін-3,5-дікарбонової кислоти
JPS55301A (en) 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
RU93052391A (ru) Способ получения амлодипинбензолсульфоната и промежуточное для него
ATE277015T1 (de) Verfahren zur herstellung von 1,4-dihydropyridine sowie in diesem verfahren verwendete verbindungen
KR930002316A (ko) N-알킬화 1,4-디하이드로피리 딘디카르복실산 에스테르
DK0531845T3 (da) Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester
DK233686D0 (da) Fremgangsmaade til fremstilling af 2-(n-benzyl-n-methylamino)-ethylmethyl-2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydro-pyridin-3,5-dicarboxylat eller hydrochloridet deraf
CO5040220A1 (es) Un procedimiento para la preparacion de clorhidrato de lercanidipino
DE60223003D1 (de) Verfahren zur herstellung von amlodipin
EP0445987A3 (en) Novel process for producing 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate-3-methyl ester-5-beta-(n-benzyl-n-methylamino)ethyl ester
ES2012687A6 (es) Procedimiento de preparacion de derivados 1,4-dihidro-piridinas.
ES551768A0 (es) Un procedimiento para la preparacion del isomero optico dextrogiro del diastereomero a del 2,6-dimetil-4-(m-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-(1-bencilpirrolidin-3-ilo) y 5-metilo
DK468385D0 (da) Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester
EP0245680A3 (en) A process for the preparation of 2-(n-benzyl-n-methylamino)-ethyl-methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylate hydrochloride
RU92005275A (ru) Способ получения 2,6-диметил-3,5-ди(карбометокси)-4-(2-нитрофенил)-1,4-дигидропиридина(нифедипина)
ES2055653A1 (es) Procedimiento de obtencion del 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isopropil-5-(2-metoxi)etil.
ITMI20021445A1 (it) Processo di sintesi industriale del isobutil metil 1,4-diidro-2,6-dimetil-4-(2-nitrofenil)piridin-3,5-dicarbossilato (nisoldipina)
JPS554318A (en) Preparation of 1,4-dihydropyridine
ES2055654A1 (es) Procedimiento de obtencion de 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil.
LV5619A3 (lv) Panemiens 2-(2-aminoetoksimetil)-4-(2-hlorfenil)-6-metil-1,4-dihidropiridina-3,5-dikarbonskabes 3-etil-5-metilestera benzolsulfoskabes sais iegusanai
RU95121073A (ru) Производные 1,4-дигидропиридин-3,5-дикарбоновой кислоты в виде r- и s-изомеров и их соли, исходные и промежуточные продукты и способ их получения
RU1828464C (ru) Способ получени диметилового эфира 1,4-дигидро-2,6-диметил-4-/2 @ -нитрофенил/-пиридин-3,5-дикарбоновой кислоты
HUT49323A (en) Process for producing azometin derivatives